Telangana Unveils Next-Gen Life Sciences Policy 2026–30 at Davos
Table of Contents
Relevance:
GS Paper II – Government Policies, Governance, International Forums
GS Paper III – Science & Technology, Biotechnology, Industrial Policy, Innovation Ecosystem
Important Keywords
For Prelims:
- Life Sciences Policy, World Economic Forum (WEF), Genome Valley, Green Pharma City, TG-iPASS, Cell and Gene Therapy, Precision Fermentation, Medical Devices Park, Biomanufacturing
For Mains:
- Life Sciences Ecosystem, Innovation-led Growth, Global Value Chains, Advanced Therapeutics, Biomanufacturing, R&D Reforms, Skill Development, Public Policy for Innovation
Why in News?
The Telangana Government unveiled the Next-Gen Life Sciences Policy 2026–30 at the annual meeting of the World Economic Forum in Davos. The policy was launched by A. Revanth Reddy in the presence of D. Sridhar Babu, Ponguleti Srinivas Reddy, senior officials and global stakeholders. The policy outlines Telangana’s ambition to attract $25 billion in investments and generate five lakh high-quality jobs by 2030.
Background and Rationale of the Policy
The new policy is intended to serve as a guiding framework for Telangana’s next phase of growth in the life sciences sector. It marks a strategic shift from a scale-driven manufacturing model to a value-led, innovation-powered growth approach, aligning the State with global trends in advanced healthcare, therapeutics and bio-manufacturing.
Vision and Targets of the Policy
The core ambition of the Next-Gen Life Sciences Policy 2026–30 is to position Telangana as a globally integrated life sciences hub across discovery, development and deployment. The State aims to:
- Rank among the top five life sciences clusters globally by 2030
- Attract $25 billion (₹2 lakh crore) in investments
- Create five lakh high-quality jobs
- Achieve deeper integration into global life sciences value chains
Industries and IT Minister D. Sridhar Babu noted that Telangana had already attracted ₹73,000 crore in investments over the last two years, and the new policy significantly raises the State’s growth ambition for the coming five years.
Stress on Cross-Border Collaboration
Chief Minister A. Revanth Reddy emphasised that the global unveiling of the policy at Davos reflects Telangana’s belief that future growth in life sciences will be driven by:
- Cross-border collaboration
- Global capital flows
- Shared innovation agendas
He stated that Telangana is building one of the world’s most trusted and transformational biosciences ecosystems, with the objective of driving global health impact from the State.
From Supply-Chain Hub to Global Originator
According to the Minister’s office, the policy represents a deliberate scale-up in ambition. Telangana seeks to transition from being indispensable to global supply chains to becoming a global originator of advanced therapies and technology platforms, especially in areas shaping the future of healthcare and sustainable bio-manufacturing.
Focus on Frontier Science and Advanced Manufacturing
A key pillar of the policy is its focus on frontier science and next-generation manufacturing platforms, including:
- Cell and gene therapies
- Peptides
- Precision fermentation
- Other next-generation therapeutic modalities
The policy also aims to strengthen the broader ecosystem covering clinical research, pharma services, diagnostics, medical electronics and digital health, positioning Telangana as a preferred global life sciences destination.
Institutional Reforms and R&D Recognition
Special Chief Secretary Sanjay Kumar highlighted that the policy is not merely a framework but a reform-oriented instrument. A major reform includes:
- Recognition of R&D units as full-fledged industrial enterprises, enabling equal access to incentives
- Promotion of breakthrough technologies such as AI, digital health and next-generation therapeutics
- Strong emphasis on nurturing skilled talent and high-value scientific activity
This reform reinforces Telangana’s commitment to innovation-driven growth.
$100 Million Life Sciences Innovation Fund
Telangana Lifesciences CEO Shakthi M. Nagappan announced the creation of a dedicated Life Sciences Innovation Fund:
- Initial corpus: ₹100 crore ($12 million)
- Scalable up to: ₹1,000 crore ($100–111 million)
The fund is intended to catalyse early- and growth-stage innovation, with a particular focus on deep-tech ventures and biotherapeutics. Another major proposal is the establishment of the Telangana School of Life Sciences, envisioned as a university of global excellence for research, education and future-ready talent development.
Infrastructure Backbone of the Policy
Policy implementation will be supported by globally benchmarked infrastructure, including:
- Green Pharma City
- Ten Pharma Villages, each spanning 1,000–3,000 acres along the ORR to promote decentralised and inclusive industrial growth
- Expansion of Genome Valley
- Further strengthening of the Medical Devices Park
- Setting up of a Bio-Innovation and Bio-Manufacturing Cluster with the Government of India
Key Provisions of the Next-Gen Life Sciences Policy 2026–30
- Creation of world-class infrastructure across the full life sciences value chain
- Faster clinical trial approvals and disease-specific clinical registries
- TG-iPASS as a single-window system with time-bound and deemed approvals
- Permission for 24×7 operations in designated life sciences parks, subject to safety norms
- Establishment of a dedicated Life Sciences Innovation Fund, scalable to ₹1,000 crore
Conclusion
The global launch of Telangana’s Next-Gen Life Sciences Policy 2026–30 at Davos marks a decisive step in the State’s evolution from a manufacturing powerhouse to an innovation-led global life sciences hub. With ambitious investment targets, strong institutional reforms, focus on frontier technologies, and globally benchmarked infrastructure, the policy aims to firmly embed Telangana in the future of global healthcare, advanced therapeutics and sustainable bio-manufacturing.
CARE MCQ
Q. TS-iPASS stands for:
- Telangana State Industrial Promotion and Support System
- Telangana Single-window Industrial Project Approval Scheme
- Telangana Industrial Project Approval and Self-Certification System
- Telangana State Investment Promotion and Approval Structure
Answer: C
Explanation:
TS-iPASS refers to the Telangana Industrial Project Approval and Self-Certification System, enacted under the TS-iPASS Act, 2014, to provide single-window, time-bound clearances for setting up industries in Telangana based on self-certification by entrepreneurs.
- Creation of world-class infrastructure across the full life sciences value chain
- Faster clinical trial approvals and disease-specific clinical registries
- TG-iPASS as a single-window system with time-bound and deemed approvals
- Permission for 24×7 operations in designated life sciences parks, subject to safety norms
- Establishment of a dedicated Life Sciences Innovation Fund, scalable to ₹1,000 crore
